Former Professor and Vice-Chair of the Department of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill and Director of McLendon Clinical Laboratories Joins LabCorp.
Life Science Partner announces the recruitment of Mark Brecher, MD, formerly Director of McLendon Clinical Laboratories at the University of North Carolina Hospitals, to the Laboratory Corporation of America (LabCorp).
LabCorp is one of the world’s largest clinical laboratory networks with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology. LabCorp performs more than one million tests on approximately 400,000 samples each day. LabCorp is a pioneer in the commercialization of new diagnostic technologies, with more than 35 years of experience in serving physicians and their patients. Brecher will fill the role of retiring Chief Medical Officer, Myla Lai-Goldman.
Brecher has been with the University of North Carolina at Chapel Hill since 1992 where he most recently served as Professor and Vice-Chair of the Department of Pathology and Laboratory Medicine, Chair of the McLendon Clinical Laboratories, Director of Clinical Pathology and the past Director of Transplantation and Transfusion Services.
In his new role at LabCorp, Brecher will have primary responsibility to oversee the clinical pathologists and laboratory technicians, lead quality for the organization, and provide insight into new technologies and services that will make LabCorp the continued leader in the clinical diagnostic arena.
“Brecher is a demonstrated leader in academic medicine – and in providing leadership to physician-led organizations,” noted Tom Callaway, President of Life Science Partner. “While he has a national reputation in transfusion medicine, but he has built a solid program at Chapel Hill of outreach to physicians seeking esoteric testing services.”
Brecher was awarded his Bachelor of Science Degree in Chemistry at Emory University and his Medical Degree from the Pritzker School of Medicine at the University of Chicago. He completed a Surgical Residency, as well as Clinical and Anatomic Pathology Residencies, at the University of Chicago School of Medicine where he served at Chief Resident.